Kyowa Kirin signs US voluntary agreement to lower US medicine costs
Kyowa Kirin announced a voluntary agreement with the U.S. government to improve access and lower the cost of medicines for American patients.
Kyowa Kirin (KY4.F, 4151.T), a Japan-based Global Specialty Pharmaceutical company, said it has reached a voluntary agreement with the U.S. government aimed at improving access to and lowering the cost of medicines for American patients. The company said it will take part in the GENEROUS mod…